Skip to main navigation Skip to search Skip to main content

Repurposing Siddha mercurial drug for mild to moderate COVID-19 – Case series and exploration of its chemical profile

  • Saravana Shiva
  • , Shanmugam Mari
  • , Arul Amuthan*
  • , Ramalingam Shanmugam
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Repurposing Siddha mercurial drug for mild to moderate COVID-19 – Case series and exploration of its chemical profile'. Together they form a unique fingerprint.
Sort by

INIS

Pharmacology, Toxicology and Pharmaceutical Science